This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Comments
Loading...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Barclays analyst Benjamin Budish initiated coverage on Blue Owl Capital Inc. OWL with an Overweight rating and announced a price target of $29. Blue Owl Cap shares closed at $22.13 on Friday. See how other analysts view this stock.
  • Citigroup analyst Thomas Palmer initiated coverage on Smithfield Foods, Inc. SFD with a Buy rating and announced a price target of $27. Smithfield Foods shares closed at $21.10 on Friday. See how other analysts view this stock.
  • Leerink Partners analyst Mike Kratky initiated coverage on Beta Bionics, Inc. BBNX with an Outperform rating and announced a price target of $28. Beta Bionics shares closed at $20.57 on Friday. See how other analysts view this stock.
  • Guggenheim analyst Michael Schmidt initiated coverage on Compass Therapeutics, Inc. CMPX with a Buy rating and announced a price target of $12. Compass Therapeutics shares closed at $2.92 on Friday. See how other analysts view this stock.
  • LifeSci Capital analyst Jimmy Shan initiated coverage on Tourmaline Bio, Inc. TRML with an Outperform rating and announced a price target of $58. Tourmaline Bio shares closed at $12.21 on Friday. See how other analysts view this stock.

Considering buying SFD stock? Here’s what analysts think:

Read This Next:

BBNX Logo
BBNXBeta Bionics Inc
$10.25-4.12%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
-
Growth
-
Quality
-
Value
15.92
Price Trend
Short
Medium
Long
Got Questions? Ask
Which food industry stocks may rally after SFD?
How will Blue Owl Capital impact the financial sector?
Could Beta Bionics disrupt biotechnologies?
What growth potential exists for Compass Therapeutics?
Which biotech companies could follow Tourmaline Bio's path?
How might Smithfield Foods perform against competitors?
What implications does SFD's rating have on meat production stocks?
Which analysts are bullish on food stocks?
What trends could affect food supply chains post-SFD rating?
Which investment firms are showing interest in SFD?
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In: